PCSC and Freenome Business Combination Update
Health
Merger Vote
Merger:
Jul 21, 2026
Industry:
MEDICAL LABORATORIES
Show Chart?
Load external content from TradingView!
*You can change or withdraw your consent at any time in the footer under Cookies.
Perceptive Capital Solutions Corp and Freenome Business Combination Update
New York, CA, USA - Perceptive Capital Solutions Corp (Nasdaq: PCSC), a special purpose acquisition company (SPAC), and Freenome Holdings, Inc., a developer of early cancer detection blood-based tests, have announced that the registration statement on Form S-4 for their proposed business combination was declared effective by the U.S. Securities and Exchange Commission (SEC) on June 17, 2026.
Transaction Details
... Read on — Members only
About Freenome Holdings, Inc.
Freenome is an early cancer detection company developing blood-based tests to detect cancer when it is most treatable. The company recognizes that no single technology can identify every cancer due to the disease’s inherent heterogeneity. Freenome’s approach combines a multiomics platform that analyzes multiple signals in the blood with artificial intelligence and machine learning to tune into cancer’s subtlest clues, even at the earliest stages of the disease.
